REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Corporacion Shaypharm S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Corporacion Shaypharm S.A. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Corporacion Shaypharm S.A. is based in Ecuador. The head office is in Quito. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. Corporacion Shaypharm S.A. was incorporated on March 22, 2016. 11 (2023) employees currently work for Corporacion Shaypharm S.A.. In 2023, the company reported a net sales revenue increase of 16.5%. Its’ total assets recorded a growth of 41.6%.

Headquarters
Av. 12 de Octubre S1-19, Urban Plaza Bldg. , Floor 19
Quito; Pichincha;

Contact Details: Purchase the Corporacion Shaypharm S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Corporacion Shaypharm S.A. report to view the information.
Outstanding Shares:
Purchase the Corporacion Shaypharm S.A. report to view the information.
Registered Capital:
Purchase the Corporacion Shaypharm S.A. report to view the information.
Incorporation Date:
March 22, 2016
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
99%
Purchase this report to view the information.
1%
Company Performance
Financial values in the chart are available after Corporacion Shaypharm S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
16.5%▲
Total operating revenue
15.11%▲
Operating profit (EBIT)
39.87%▲
Net Profit (Loss) for the Period
N/A
Total assets
41.6%▲
Total equity
194.92%▲
Operating Profit Margin (ROS)
1.46%▲
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
0.31%▲
Cash Ratio
0.3%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo